A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB.
Open Access
- 1 March 1996
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 183 (3) , 777-789
- https://doi.org/10.1084/jem.183.3.777
Abstract
The costimulatory molecule B7.1 provides a second signal critical for T cell activation. The distribution of this integral membrane protein is restricted to certain tissues where its level of expression is modulated by multiple exogenous stimuli. To identify the molecular basis for specificity and inducibility, the chromatin configuration of the human B7.1 gene was examined in intact nuclei from various cell types. The identification of a tissue-specific deoxyribonuclease I hypersensitive site approximately 3kb upstream of the transcription start site led to the characterization of a cell type-specific enhancer region. This 183-bp region was both cell type specific and responsive to two distinct stimuli, lipopolysaccharide and dibutyryl cAMP, known to regulate B7.1 expression. Deletional and site-directed mutagenesis revealed the presence of multiple functionally critical cis elements within this region, one of which was a nuclear factor (NF)-kappaB consensus sequence. In B7.1-positive B cells, this element bound several members of the NF-kappaB family, transcription factors already implicated in signal transduction pathways relevant to B7.1 expression. This is the first description, to our knowledge, of regulatory elements that control expression of a gene encoding a B7 costimulatory molecule.Keywords
This publication has 67 references indexed in Scilit:
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity, 1994
- A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells.The Journal of Experimental Medicine, 1994
- In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2Immunity, 1994
- Signals and signs for lymphocyte responsesCell, 1994
- Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.The Journal of Experimental Medicine, 1993
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7Immunogenetics, 1992
- Isolation of an Active Human Transposable ElementScience, 1991
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.The Journal of Experimental Medicine, 1991